Serial Studies of Peripheral Blood Myeloma Cells in Patients with Multiple Myeloma: When is the Optimal Time for Stem Cell Harvest?

References

• Gertz M., Pineda A., Chen M., Letendre L., Greipp P., Solberg L., Jr., Witzig T., Garton J., Inwards D., Litzow M., Tefferi A., Kyle R., Nöel P. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am. J. Med. Sci., In press
   PubMedGoogle Scholar
• Dimopoulos M., Alexanian R., Przepiorka D., Hester J., Andersson B., Giralt S., Mehra R., van Besien K., Delasalle K., Reading C., Deisseroth A., Champlin R. Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324–2328
   PubMed Web of Science ®Google Scholar
• Fermand J.-P., Chevret S., Ravaud P., Divine M., Leblond V., Dreyfus F., Mariette X., Brouet J.-C. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005–2009
   PubMed Web of Science ®Google Scholar
• Jagannath S., Barlogie B., Dicke K., Alexanian R., Zagars G., Cheson B., Lemaistre F., Smallwood L., Pruitt K., Dixon D. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860–1866
   PubMed Web of Science ®Google Scholar
• Ventura G., Barlogie B., Hester J., Yau J., Le Maistre C., Wallerstein R., Spinolo J., Dicke K., Horwitz L., Alexanian R. High dose cyclophosphamide, BCNU, and VP-16 with autologous blood stem cell support for refractory multiple myeloma. Bone Marrow Transplant. 1990; 9: 11–17
   Google Scholar
• Schiller G., Nimer S., Vescio R., Lieb G., Lee M., Gajewski J., Territo M., Berenson J. Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma. Bone Marrow Transplant. 1994; 14: 131–136
   PubMed Web of Science ®Google Scholar
• Ginsberg D. Circulating plasma cells in multiple myeloma: a method for detection and review of the problem. Ann Int. Med. 1962; 57: 843–846
   PubMed Web of Science ®Google Scholar
• Bakkus M., Van Riet I., Van Camp B., Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br. J. Haematol. 1994; 87: 68–74
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichtenstein A. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Biberfeld P., Mellstedt H., Pettersson D. Ultrastructural and immunochemical characterization of circulating mononuclear cells in patients with myelomatosis. Acta Path. Microbiol. Scand. 1977; 85: 611–624
   Google Scholar
• Billadeau D., Quam L., Thomas W., Kay N., Greipp P., Kyle R., Oken M., Van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818–1824
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Gavarotti P., Fossati G., Massaia M., Pileri A., Durie B. Kinetics of circulating B-lymphocytes in human myeloina. Blood 1983; 61: 812–814
   PubMed Web of Science ®Google Scholar
• Cassel A., Leibovitz N., Hornstein L., Quitt M., Aghai E. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp. Hematol. 1990; 18: 1171–1173
   PubMed Web of Science ®Google Scholar
• Fend F., Weyrer K., Drach J., Schwaiger A., Umlauft F., Grünewald K. Immunoglobulin gene rearrangement in plasma cell dyscrasias: detection of small clonal cell populations in peripheral blood and bone marrow. Leuk. Lymphoma 1993; 16: 223–229
   Web of Science ®Google Scholar
• Jensen G., Mant M., Belch A., Berenson J., Ruether B., Pilarski L. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78: 711–719
   PubMed Web of Science ®Google Scholar
• Joshua D., Ioannidis R., Brown R., Francis S., Gibson J., Kronenberg H. Multiple myeloma: relationship between light chain isotype suppression, labeling index of plasma cells and CD38 expression on peripheral blood lymphocytes. Am. J. Hematol. 1988; 29: 5–11
   PubMed Web of Science ®Google Scholar
• Österborg A., Steinitz M., Lewin N., Bergenbrant S., Holm G. A-K., Lefvert Mellstedt H. Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood 1991; 78: 2642–2649
   PubMed Web of Science ®Google Scholar
• Witzig T., Dhodapkar M., Kyle R., Greipp P. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993; 72: 108–113
   PubMed Web of Science ®Google Scholar
• Morissette L., Watkins C. Multiple myeloma: diagnostic value of the blood smear. Mayo Clin. Proc. 1942; 17: 433–439
   Google Scholar
• Omedé P., Boccadoro M., Gallone G., Frieri R., Battaglio S., Redoglia V., Pileri A. Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 1990; 76: 1375–1379
   PubMed Web of Science ®Google Scholar
• Ruiz-Argüelles G., Katzmann J., Greipp P., Gonchoroff N., Garton J., Kyle R. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood 1984; 64: 352–356
   PubMed Web of Science ®Google Scholar
• Witzig T. Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applications. Mayo Clin. Proc. 1994; 69: 903–907
   PubMed Web of Science ®Google Scholar
• Greipp P. Monoclonal garnmopathies: new approaches to clinical problems in diagnosis and prognosis. Blood Rev. 1989; 3: 222–236
   PubMed Web of Science ®Google Scholar
• Witzig T., Kyle R., O'Fallon W., Greipp P. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smoldering multiple myeloma. Br. J. Haematol. 1994; 87: 266–272
   PubMed Web of Science ®Google Scholar
• Witzig T., Gonchoroff N., Ahmann G., Katzmann J., Greipp P. T-cell depletion wing anti-CD2 coated magnetic beads simplifies the detection of peripheral blood plasmacells. J. Immunol. Methods 1991; 144: 253–256
   PubMed Web of Science ®Google Scholar
• Witzig T., Gonchoroff N., Katzmann J., Therneau T., Kyle R., Greipp P. Peripheral blood B-cell labeling indices are a measure of disease activity in patients with monoclonal gamopathies. J. Clin. Oncol. 1988; 6: 1041–1046
   PubMed Web of Science ®Google Scholar
• Kruskal W., Wallis W. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 1952; 47
   Web of Science ®Google Scholar
• Pettersson D., Mellstedt H., Holm G., Bjøorkholm M. Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scand. J. Haematol. 1981; 27: 287–293
   PubMedGoogle Scholar
• Bagg A., Becker P., Bezwoda W., Van Rensburg L., Mendelow B. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins. Br. J. Haematol. 1989; 72: 167–172
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Omedé P., Massaia M., Dianzani U., Pioppo P., Battaglio S., Meregalli M., Pileri A. Human myeloma: several subsers of circulating lymphocytes express plasma cell-associated antigens. Eur. J. Haematol. 1988; 40: 299–304
   PubMed Web of Science ®Google Scholar
• Büchi G., Giorotta M., Veglío M., Clerico M., Gario S, Termine G., Autino K. Kappa/lamhda ritio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies. Haematologica 1990; 75: 132–136
   PubMedGoogle Scholar
• Chiu E., Ganeshaguru K., Hoffbrand A., Mehta A. Circulating monoclonal B lymphocytes in multiple myeloma. Br. J. Haematol. 1989; 72: 28–31
   PubMed Web of Science ®Google Scholar
• Mellstedt H., Pettersson D., Holm G. Monoclonal B-lymphocytes in peripheral blood of patients with plasma cell myeloma: relation to activity of disease. Scand. J. Haematol. 1976; 16: 112–120
   PubMedGoogle Scholar
• Shimizu K., Murate T., Kunii A. Circulating immunoglobulin-secreting cells in patients with plasma cell dyscrasia. Blood 1980; 55: 590–594
   PubMed Web of Science ®Google Scholar
• Witzig T., Gertz M., Pineda A., Kyle R., Greipp P. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br. J. Haematol., In press
   Google Scholar